Elicio Therapeutics, Inc. Common Stock (ELTX) is a publicly traded Healthcare sector company. As of September 24, 2026, ELTX trades at $1.91 with a market cap of $49.15M and a P/E ratio of -0.73. ELTX moved +2.94% today. Year to date, ELTX is -76.77%; over the trailing twelve months it is -83.14%. Its 52-week range spans $1.71 to $16.00. Analyst consensus is buy with an average price target of $23.00. Rallies surfaces ELTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover ELTX: 0 strong buy, 1 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $23.00.
| Metric | Value |
|---|---|
| Price | $1.91 |
| Market Cap | $49.15M |
| P/E Ratio | -0.73 |
| EPS | $-2.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.00 |
| 52-Week Low | $1.71 |
| Volume | 43.68K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.57M |
| Gross Margin | 0.00% |
2 analysts cover ELTX: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $23.00.